✦ LIBER ✦

Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer

✍ Scribed by Moehler, M; Eimermacher, A; Siebler, J; Höhler, T; Wein, A; Menges, M; Flieger, D; Junginger, T; Geer, T; Gracien, E

Book ID: 109998550
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 130 KB
Volume: 92
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6602649

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I–II trial of weekly gemcitabine p

Phase I–II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer

✍ HER-SHYONG SHIAH; ANN-LII CHENG; CHIUN HSU; CHIH-HUNG HSU; TSANG-WU LIU; JANG-YA 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

A phase 2 study of weekly high-dose 5-fl

A phase 2 study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric cancer

✍ Maurie Markman 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 73 KB

A phase II study of weekly high-dose 5-f

A phase II study of weekly high-dose 5-fluorouracil and leucovorin plus biweekly alternating doxorubicin and cisplatin for advanced gastric carcinoma

✍ M. Raida; R. Kath; M. Arnrich; G. Kähler; J. Scheele; K. Höffken 📂 Article 📅 1998 🏛 Springer-Verlag 🌐 English ⚖ 277 KB

Phase II multicentre randomised study of

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer

✍ Bonneterre, J; Dieras, V; Tubiana-Hulin, M; Bougnoux, P; Bonneterre, M-E; Delozi 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

A phase II trial of weekly high dose con

A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer

✍ Enrique Aranda; Andrés Cervantes; Javier Dorta; Esperanza Blanco; Carlos Fernánd 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

Protracted continuous infusion of 5-fluo

Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study

✍ Alfredo Falcone; Giacomo Allegrini; Monica Lencioni; Elisabetta Pfanner; Isa Bru 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 72 KB